Rxo Inc (RXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,774,000 | 1,425,000 | 1,469,000 | 1,421,000 | 1,419,000 |
| Cost of Goods | 1,525,000 | 1,221,000 | 1,250,000 | 1,185,000 | 1,165,000 |
| Gross Profit | 249,000 | 204,000 | 219,000 | 236,000 | 254,000 |
| Operating Expenses | 248,000 | 232,000 | 261,000 | 243,000 | 254,000 |
| Operating Income | 1,000 | -28,000 | -42,000 | -7,000 | N/A |
| Interest Expense | 9,000 | 9,000 | 9,000 | 9,000 | 8,000 |
| Other Income | 0 | -12,000 | 0 | 1,000 | -2,000 |
| Pre-tax Income | -8,000 | -49,000 | -51,000 | -15,000 | -10,000 |
| Income Tax | 1,000 | -13,000 | -5,000 | -1,000 | -1,000 |
| Net Income Continuous | -9,000 | -36,000 | -46,000 | -14,000 | -9,000 |
| Net Income | $-9,000 | $-36,000 | $-46,000 | $-14,000 | $-9,000 |
| EPS Basic Total Ops | -0.05 | -0.21 | -0.28 | -0.08 | -0.05 |
| EPS Basic Continuous Ops | -0.05 | -0.21 | -0.27 | -0.08 | -0.05 |
| EPS Diluted Total Ops | -0.05 | -0.21 | -0.28 | -0.08 | -0.05 |
| EPS Diluted Continuous Ops | -0.05 | -0.21 | -0.27 | -0.08 | -0.05 |
| EPS Diluted Before Non-Recurring Items | 0.06 | -0.09 | -0.07 | 0.01 | 0.04 |
| EBITDA(a) | $27,000 | $-2,000 | $-14,000 | $19,000 | $30,000 |